Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 76.07% vs 8.74% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 28.44% vs 26.23% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 840.00% vs 0.00% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 66.22% vs 28.33% in Mar 2025
Compare Balance Sheet Results of Oxygenta Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
36.98
11.45
25.53
222.97%
Share Warrants & Outstandings
Total Reserve
-79.67
62.07
-141.74
-228.36%
Shareholder's Funds
-42.69
73.51
-116.20
-158.07%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
75.29
2.67
72.62
2,719.85%
Secured Loans
23.17
2.67
20.50
767.79%
Unsecured Loans
52.11
0.00
52.11
0.00%
Deferred Tax Assets / Liabilities
-17.41
0.72
-18.13
-2,518.06%
Other Long Term Liabilities
0.00
0.08
-0.08
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.98
0.00
0.98
0.00%
Total Non-Current Liabilities
58.86
3.47
55.39
1,596.25%
Current Liabilities
Trade Payables
48.77
13.77
35.00
254.18%
Other Current Liabilities
2.79
3.28
-0.49
-14.94%
Short Term Borrowings
34.28
5.69
28.59
502.46%
Short Term Provisions
0.26
3.81
-3.55
-93.18%
Total Current Liabilities
86.10
26.56
59.54
224.17%
Total Liabilities
102.27
103.55
-1.28
-1.24%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
74.58
148.73
-74.15
-49.86%
Less: Accumulated Depreciation
26.98
102.07
-75.09
-73.57%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
47.60
46.66
0.94
2.01%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
2.97
-2.97
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.47
0.20
0.27
135.00%
Long Term Loans & Advances
1.00
0.44
0.56
127.27%
Other Non Current Assets
1.77
0.36
1.41
391.67%
Total Non-Current Assets
50.84
50.87
-0.03
-0.06%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
29.42
28.35
1.07
3.77%
Sundry Debtors
10.03
19.30
-9.27
-48.03%
Cash and Bank
2.15
2.27
-0.12
-5.29%
Other Current Assets
7.47
2.38
5.09
213.87%
Short Term Loans and Advances
2.36
0.39
1.97
505.13%
Total Current Assets
51.43
52.68
-1.25
-2.37%
Net Current Assets (Including Current Investments)
-34.67
26.12
-60.79
-232.73%
Total Current Assets Excluding Current Investments
51.43
52.68
-1.25
-2.37%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
102.27
103.55
-1.28
-1.24%
Contingent Liabilities
0.16
2.50
-2.34
-93.60%
Total Debt
109.57
8.37
101.20
1,209.08%
Book Value per share (adjusted)
-11.54
64.22
-75.76
-117.97%
Annual - Borrowings
Borrowings 109.57 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 76.07% vs 8.74% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 47.60 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 28.44% vs 26.23% in Mar 2025
Annual - Investments
Investments 0.47 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 840.00% vs 0.00% in Mar 2025
Annual - Current Assets
Current Assets 51.43 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 66.22% vs 28.33% in Mar 2025
